Retrospective study on effectiveness of combination drugs for hypertension -Consideration on blood-pressure control before and after switch from concomitant use of single drugs to combination drug
Not Applicable
- Conditions
- hypertension
- Registration Number
- JPRN-UMIN000021935
- Lead Sponsor
- aboratory of pharmacotherapeutics, Tokyo University of Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of blood-pressure before and after switching concomitant use of single drugs to combination drug
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie improved blood-pressure control in combination antihypertensive therapies studied in JPRN-UMIN000021935?
How does the efficacy of switching to combination antihypertensive drugs in JPRN-UMIN000021935 compare to standard-of-care monotherapy regimens?
Which biomarkers correlate with response to combination drug therapy in hypertension patients from JPRN-UMIN000021935's retrospective analysis?
What adverse events are reported in JPRN-UMIN000021935's observational study of combination antihypertensive drug use?
How do alternative combination approaches (e.g., ACEi/ARB + CCB) in hypertension management compare to JPRN-UMIN000021935's methodology?